BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2005
View Archived Issues
Serotonin 5-HT7 receptor as a target for depression and other psychiatric diseases
Read More
Dendritic cell-targeted immunosuppressive actions of JM-34
Read More
Antipsychotic efficacy of bifeprunox mesilate
Read More
Cytos Biotechnology and Medarex expand collaboration
Read More
BioTie and sanofi-aventis to negotiate extension of agreement to develop oral heparin-like product
Read More
Halozyme files an NDA for Enhanze SC
Read More
Osiris cleared to begin stem cell trial for knee repair
Read More
Sepracor to launch Lunesta
Read More
Treatment begins in phase III study of tolevamer in CDAD
Read More
Phase III trial completed for Bio-E-Gel
Read More
Acorda launches Zanaflex Capsules
Read More
Novel PAR-2 antagonists presented by Kowa
Read More
Nuvelo and Kirin to develop NU-206
Read More
T-817MA alleviates oxidative stress in rat cortical neurons
Read More
Ligand earns milestone from TAP's IND filing
Read More
Recent Roche patents describe therapeutic agents for genitourinary disorders
Read More
Novel antiarthritic agents imparted by Cellular Genomics
Read More
New treatments for cardiovascular disorders claimed in recent patent literature
Read More
Japanese sales release of Zione Injection products
Read More
Peptide YY3-36 reduces food intake through taste aversion
Read More
Janus files IND for JA-001
Read More
Adoptive cell transfer demonstrates activity in metastatic melanoma patients
Read More
ATPase studied in new phase II trial
Read More
Curis and Genentech form second major collaboration
Read More
Phase III study of VP-002 for central precocious puberty completes enrollment
Read More